The Antinociceptive Activity of (E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide in Mice Is Reduced by (E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide Through Opposing Modulatory Mechanisms at the & alpha;7 Nicotinic Acetylcholine Receptor

BACKGROUND:The primary objective of this study was to characterize the pharmacological and behavioral activity of 2 novel compounds, DM497 [(E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide] and DM490 [(E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide], structural derivatives of PAM-2, a positive allosteric modulator of the & alpha;7 nicotinic acetylcholine receptor (nAChR). METHODS:A mouse model of oxaliplatin-induced neuropathic pain (2.4 mg/kg, 10 injections) was used to test the pain-relieving properties of DM497 and DM490. To assess possible mechanisms of action, the activity of these compounds was determined at heterologously expressed & alpha;7 and & alpha;9 & alpha;10 nAChRs, and voltage-gated N-type calcium channel (Ca(V)2.2) using electrophysiological techniques. RESULTS:Cold plate tests indicated that 10 mg/kg DM497 was able to decrease neuropathic pain in mice induced by the chemotherapeutic agent oxaliplatin. In contrast, DM490 induced neither pro- nor antinociceptive activity but inhibited DM497's effect at equivalent dose (30 mg/kg). These effects are not a product of changes in motor coordination or locomotor activity. At & alpha;7 nAChRs, DM497 potentiated whereas DM490 inhibited its activity. In addition, DM490 antagonized the & alpha;9 & alpha;10 nAChR with >8-fold higher potency than that for DM497. In contrast, DM497 and DM490 had minimal inhibitory activity at the Ca(V)2.2 channel. Considering that DM497 did not increase the mouse exploratory activity, an indirect anxiolytic mechanism was not responsible for the observed antineuropathic effect. CONCLUSIONS:The antinociceptive activity of DM497 and the concomitant inhibitory effect of DM490 are mediated by opposing modulatory mechanisms on the & alpha;7 nAChR, whereas the involvement of other possible nociception targets such as the & alpha;9 & alpha;10 nAChR and Ca(V)2.2 channel can be ruled out.

Automated summary

The study aimed to characterize the pharmacological and behavioral activity of two novel compounds, DM497 and DM490. It was found that DM497 could relieve neuropathic pain induced by oxaliplatin, while DM490 inhibited its effect at the same dose. These effects were not associated with changes in motor coordination or locomotor activity.